Want to see KR:002210 full AI Analyst Report?
Dongsung Pharmaceutical Co., Ltd. (002210) Income Statement
Dongsung Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q2 2026), Dongsung Pharmaceutical Co., Ltd.'s total revenue was $22.08B, an increase of 10.64% from the same quarter last year. In Q2, Dongsung Pharmaceutical Co., Ltd.'s net income was $-5.89B. See Dongsung Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 87.17B | $ 88.45B | $ 88.59B | $ 93.33B | $ 84.41B | |
| $ 36.36B | $ 38.88B | $ 41.37B | $ 42.06B | $ 33.54B | |
| $ 59.23B | $ 45.48B | $ 40.77B | $ 45.15B | $ 38.84B | |
| Depreciation and Amortization | $ 2.14B | $ 2.04B | $ 2.05B | $ 2.12B | $ 2.22B |
| $ -20.73B | $ -1.88B | $ 3.42B | $ 1.58B | $ -1.44B | |
| $ -22.87B | $ -6.59B | $ 596.40M | $ -2.04B | $ -5.30B | |
| $ -5.82B | $ -1.06B | $ -1.46B | $ 191.20M | $ 919.71M | |
| $ -28.69B | $ -7.66B | $ -865.89M | $ -1.85B | $ -4.38B | |
| $ -25.74B | $ -7.25B | $ -2.07B | $ -2.12B | $ -4.31B | |
| Per Share Metrics | |||||
| Basic EPS | $ -1125.56 | $ -317.64 | $ -90.70 | $ -92.23 | $ -184.52 |
| Diluted EPS | $ -1125.56 | $ -317.20 | $ -86.74 | $ -87.74 | $ -184.29 |
| Weighted Average Shares Outstanding | 22.87M | 22.87M | 22.87M | 23.00M | 23.37M |
| Weighted Average Shares Outstanding (Diluted) | 22.87M | 22.87M | 23.91M | 24.18M | 23.40M |
Currency in KRW